{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-25-000069","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.010857+00:00","generated_at":"2026-05-17T00:33:46.440065+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Exagen Q3 revenue $17.2M (+38% YoY), record; net loss $7.1M; guides FY rev $65-70M","bullets":["Revenue $17.2M up 38% YoY; net loss $7.1M vs $5.0M loss last year.","Adjusted EBITDA loss narrowed to $1.9M from $4.0M; gross margin improved to 58.4%.","AVISE CTD test volume up 16% YoY; ASP $441 (+$37 YoY).","Cash at $35.7M, up from $30.0M in Q2 2025.","FY2025 revenue guidance $65-70M; expects positive adjusted EBITDA in Q4 at high end."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-25-000069","json":"https://secwatch.observer/filing/0001274737-25-000069.json","markdown":"https://secwatch.observer/filing/0001274737-25-000069.md","text":"https://secwatch.observer/filing/0001274737-25-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000069/0001274737-25-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000069/exdx-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:33:46.440065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}